Hospital
Upmc Jameson
Upmc Jameson was paid $6.82M by Medicaid between Jan 2018 and Dec 2024, across 260 billing codes. Its largest line is 99284, emergency room visit (serious) — 32% of everything it billed.
33Billing provider infoUPMC JAMESON
NEW CASTLE, PA 16105
NEW CASTLE, PA 16105
33aNPI1477538312assigned 12/14/2005
33bProvider typeGeneral Acute Care Hospital
28Total paid$6.82M
24GClaims241,684
24DCodes billed260
24AFirst – last monthJan 2018 – Dec 2024
Compared with peers
Next to other General Acute Care Hospital providers in Pennsylvania
Rank by total paid#47 of 154
Median peer was paid$2.82M
This provider vs. median2.4×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 117 | $6K | |
| 2019 | 250 | $12K | |
| 2020 | 21,942 | $512K | |
| 2021 | 112,403 | $3.09M | |
| 2022 | 34,150 | $1.02M | |
| 2023 | 40,063 | $1.14M | |
| 2024incomplete | 32,759 | $1.04M |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 32% | 18,972 | 18,204 | $2.17M |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 14% | 5,744 | 5,522 | $938K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 11% | 8,892 | 8,611 | $731K |
| G0378 | Hospital observation service, per hour | 4.3% | 1,027 | 414 | $295K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | 2.9% | 1,260 | 1,234 | $196K |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | 2.7% | 7,471 | 7,095 | $187K |
| T1015 | A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive | 2.5% | 5,882 | 5,416 | $172K |
| 80053 | Comprehensive metabolic panel | 2.2% | 14,655 | 13,674 | $150K |
| 0241U | Neonatal screening for hereditary disorders, genomic sequence analysis panel | 1.7% | 2,205 | 2,179 | $119K |
| 70450 | Computed tomography, head or brain; without contrast material | 1.6% | 1,989 | 1,890 | $106K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.4% | 19,268 | 17,600 | $96K |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | 1.3% | 1,942 | 1,719 | $91K |
248 more codes
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 835 | $63K |
| U0003 | Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r | <1% | 757 | $57K |
| 80050 | General health panel | <1% | 1,232 | $55K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 3,418 | $54K |
| 71275 | Computed tomographic angiography, chest, with contrast material | <1% | 297 | $51K |
| 71046 | Radiologic examination, chest; 2 views | <1% | 3,676 | $48K |
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 5,086 | $45K |
| 73721 | Magnetic resonance imaging, any joint of lower extremity; without contrast material | <1% | 178 | $43K |
| 84484 | <1% | 5,154 | $41K | |
| 43239 | Esophagogastroduodenoscopy, flexible, transoral; with biopsy, single or multiple | <1% | 234 | $37K |
| 77067 | Screening mammography, bilateral, including computer-aided detection | <1% | 423 | $35K |
| 80061 | Lipid panel | <1% | 2,941 | $35K |
| 72148 | Magnetic resonance imaging, lumbar spine; without contrast material | <1% | 218 | $33K |
| 70553 | Magnetic resonance imaging, brain; without contrast material, followed by contrast material and further sequences | <1% | 170 | $33K |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 4,167 | $33K |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | <1% | 957 | $27K |
| 93306 | Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete | <1% | 414 | $26K |
| 84443 | Thyroid stimulating hormone (TSH) | <1% | 1,197 | $25K |
| M0243 | Intravenous infusion or subcutaneous injection, casirivimab and imdevimab includes infusion or injection, and post administration monitoring | <1% | 54 | $20K |
| 72125 | Computed tomography, cervical spine; without contrast material | <1% | 372 | $20K |
| 71045 | Radiologic examination, chest; single view | <1% | 3,035 | $20K |
| 70551 | Magnetic resonance imaging, brain; without contrast material | <1% | 104 | $19K |
| 76830 | Ultrasound, transvaginal | <1% | 426 | $19K |
| 76811 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation, detailed | <1% | 196 | $18K |
| 83735 | <1% | 3,468 | $18K | |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | <1% | 166 | $18K |
| 83605 | <1% | 2,707 | $18K | |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 1,314 | $16K |
| 71250 | <1% | 307 | $16K | |
| 93971 | <1% | 304 | $16K | |
| 71260 | Computed tomography, thorax, diagnostic; with contrast material | <1% | 246 | $15K |
| 83690 | <1% | 3,179 | $14K | |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 600 | $14K |
| 76705 | Ultrasound, abdominal, real time with image documentation; limited | <1% | 424 | $13K |
| 76816 | Ultrasound, pregnant uterus, real time with image documentation, follow-up | <1% | 293 | $13K |
| 76801 | <1% | 303 | $13K | |
| 83880 | <1% | 541 | $12K | |
| 76856 | Ultrasound, pelvic (nonobstetric), real time with image documentation; complete | <1% | 263 | $12K |
| 76536 | <1% | 262 | $12K | |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 5,010 | $11K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 400 | $11K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | <1% | 272 | $11K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | <1% | 255 | $11K |
| 81003 | <1% | 3,595 | $10K | |
| 62323 | <1% | 125 | $10K | |
| 85610 | <1% | 3,729 | $10K | |
| 83036 | Hemoglobin; glycosylated (A1C) | <1% | 1,669 | $10K |
| 72100 | <1% | 467 | $10K | |
| 76770 | <1% | 283 | $10K | |
| 76817 | Ultrasound, pregnant uterus, real time with image documentation, transvaginal | <1% | 166 | $9K |
| 93970 | <1% | 142 | $9K | |
| 77063 | Screening digital breast tomosynthesis, bilateral | <1% | 417 | $9K |
| 87088 | <1% | 1,272 | $8K | |
| 85730 | <1% | 1,718 | $8K | |
| 80329 | <1% | 700 | $8K | |
| 72141 | <1% | 40 | $8K | |
| 86803 | <1% | 374 | $7K | |
| 82607 | <1% | 618 | $7K | |
| 76642 | <1% | 182 | $7K | |
| 72020 | <1% | 701 | $7K | |
| 84702 | <1% | 437 | $7K | |
| 73564 | <1% | 320 | $6K | |
| 81025 | <1% | 1,747 | $6K | |
| 81015 | <1% | 2,534 | $6K | |
| 95886 | <1% | 138 | $6K | |
| 88305 | Level IV - Surgical pathology, gross and microscopic examination | <1% | 553 | $6K |
| 73610 | <1% | 377 | $6K | |
| 84439 | <1% | 767 | $6K | |
| 73030 | <1% | 396 | $6K | |
| 87040 | <1% | 593 | $6K | |
| 74018 | <1% | 435 | $5K | |
| 80076 | <1% | 644 | $5K | |
| 90715 | <1% | 389 | $5K | |
| 85027 | <1% | 934 | $5K | |
| 93017 | <1% | 151 | $5K | |
| 82728 | <1% | 460 | $5K | |
| 73630 | <1% | 467 | $5K | |
| 85379 | <1% | 489 | $4K | |
| A9577 | Injection, gadobenate dimeglumine (multihance), per ml | <1% | 763 | $4K |
| 84100 | <1% | 906 | $4K | |
| 73502 | <1% | 279 | $4K | |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 7,677 | $4K |
| 72110 | <1% | 193 | $4K | |
| 78452 | Myocardial perfusion imaging, tomographic (SPECT); multiple studies at rest and/or stress | <1% | 30 | $4K |
| 83540 | <1% | 558 | $4K | |
| 94729 | <1% | 151 | $4K | |
| 84703 | <1% | 370 | $4K | |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 446 | $4K |
| J1815 | Injection, insulin, per 5 units | <1% | 326 | $4K |
| 87077 | <1% | 631 | $4K | |
| 77066 | Tomosynthesis, mammo | <1% | 47 | $4K |
| 73221 | <1% | 14 | $4K | |
| 70486 | <1% | 50 | $4K | |
| 87186 | <1% | 525 | $4K | |
| 82043 | <1% | 487 | $3K | |
| 94726 | <1% | 148 | $3K | |
| Q3014 | Telehealth originating site facility fee | <1% | 217 | $3K |
| 73130 | <1% | 309 | $3K | |
| 45385 | Colonoscopy, flexible; with removal of tumor(s), polyp(s), or other lesion(s) | <1% | 13 | $3K |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 129 | $3K |
| 86038 | <1% | 212 | $3K | |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 124 | $3K |
| 83970 | <1% | 78 | $3K | |
| J3490 | Unclassified drugs | <1% | 2,375 | $3K |
| 76700 | Ultrasound, abdominal, real time with image documentation; complete | <1% | 62 | $3K |
| 73110 | <1% | 286 | $3K | |
| 86140 | <1% | 1,015 | $3K | |
| G0279 | Diagnostic digital breast tomosynthesis, unilateral or bilateral (list separately in addition to 77065 or 77066) | <1% | 175 | $3K |
| 82746 | <1% | 243 | $3K | |
| 72050 | <1% | 109 | $2K | |
| 45378 | Colonoscopy, flexible; diagnostic, including collection of specimen(s) | <1% | 12 | $2K |
| 85652 | <1% | 913 | $2K | |
| 86480 | <1% | 39 | $2K | |
| 84153 | <1% | 103 | $2K | |
| 80081 | <1% | 26 | $2K | |
| 82550 | <1% | 354 | $2K | |
| 84436 | <1% | 211 | $2K | |
| 83550 | <1% | 462 | $2K | |
| 82962 | <1% | 1,216 | $2K | |
| G0463 | Hospital outpatient clinic visit for assessment and management of a patient | <1% | 282 | $2K |
| 82565 | <1% | 339 | $2K | |
| 93226 | <1% | 57 | $2K | |
| 82784 | <1% | 121 | $2K | |
| 45380 | Colonoscopy, flexible; with biopsy, single or multiple | <1% | 12 | $2K |
| 86850 | <1% | 271 | $2K | |
| 72040 | <1% | 113 | $2K | |
| 77065 | Tomosynthesis, mammo | <1% | 32 | $2K |
| J1170 | Injection, hydromorphone, up to 4 mg | <1% | 3,018 | $2K |
| 82150 | <1% | 347 | $2K | |
| 95911 | <1% | 27 | $2K | |
| 73560 | <1% | 112 | $1K | |
| 94060 | <1% | 154 | $1K | |
| 87389 | Infectious agent antigen detection by immunoassay technique, HIV-1 antigen with HIV-1 and HIV-2 antibodies | <1% | 51 | $1K |
| 84480 | <1% | 174 | $1K | |
| 84460 | <1% | 208 | $1K | |
| 73562 | <1% | 92 | $1K | |
| 76815 | Ultrasound, pregnant uterus, real time with image documentation, limited | <1% | 35 | $1K |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 4,878 | $1K |
| 93041 | <1% | 299 | $1K | |
| 76805 | Ultrasound, pregnant uterus, real time with image documentation, fetal and maternal evaluation | <1% | 24 | $1K |
| 84450 | <1% | 182 | $1K | |
| 96366 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; each additional hour | <1% | 144 | $1K |
| 82977 | <1% | 143 | $1K | |
| 11043 | <1% | 23 | $1K | |
| 73590 | <1% | 91 | $1K | |
| 86901 | <1% | 304 | $997.67 | |
| 86900 | <1% | 304 | $982.41 | |
| J2930 | Injection, methylprednisolone sodium succinate, up to 125 mg | <1% | 357 | $977.92 |
| 84520 | <1% | 221 | $970.72 | |
| J2785 | Injection, regadenoson, 0.1 mg | <1% | 84 | $943.84 |
| 84403 | <1% | 27 | $915.24 | |
| 73090 | <1% | 95 | $888.22 | |
| 86618 | <1% | 42 | $884.15 | |
| 84550 | <1% | 158 | $855.55 | |
| 93225 | <1% | 57 | $800.28 | |
| 97597 | <1% | 36 | $789.00 | |
| 93296 | <1% | 76 | $786.60 | |
| 87070 | <1% | 176 | $753.84 | |
| 87340 | <1% | 56 | $752.47 | |
| 96360 | Intravenous infusion, hydration; initial, 31 minutes to 1 hour | <1% | 41 | $647.74 |
| J1040 | Injection, methylprednisolone acetate, 80 mg | <1% | 162 | $605.60 |
| 73080 | <1% | 56 | $591.80 | |
| 83615 | <1% | 96 | $590.49 | |
| 87205 | <1% | 184 | $588.39 | |
| 80348 | <1% | 12 | $579.34 | |
| 82805 | <1% | 16 | $575.55 | |
| 72070 | <1% | 33 | $574.55 | |
| 82248 | <1% | 109 | $545.41 | |
| 86592 | <1% | 126 | $506.73 | |
| 82570 | <1% | 74 | $498.25 | |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | <1% | 1,277 | $497.95 |
| J3535 | Drug administered through a metered dose inhaler | <1% | 43 | $495.20 |
| 86706 | <1% | 39 | $474.05 | |
| A9500 | Technetium tc-99m sestamibi, diagnostic, per study dose | <1% | 12 | $457.10 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 5,239 | $455.81 |
| 70496 | <1% | 12 | $440.44 | |
| J7120 | Ringers lactate infusion, up to 1000 cc | <1% | 1,778 | $424.30 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 1,991 | $417.85 |
| 36415 | Collection of venous blood by venipuncture | <1% | 2,308 | $389.44 |
| 80197 | <1% | 18 | $380.52 | |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | <1% | 676 | $365.43 |
| 80345 | <1% | 27 | $360.61 | |
| 82947 | <1% | 120 | $354.85 | |
| J0780 | Injection, prochlorperazine, up to 10 mg | <1% | 325 | $311.51 |
| J7050 | Infusion, normal saline solution, 250 cc | <1% | 3,632 | $306.91 |
| 84146 | <1% | 13 | $280.32 | |
| 20552 | <1% | 12 | $280.15 | |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 289 | $270.44 |
| 80361 | <1% | 12 | $268.80 | |
| J1644 | Injection, heparin sodium, per 1000 units | <1% | 1,013 | $264.67 |
| 84481 | <1% | 12 | $246.12 | |
| 76942 | <1% | 43 | $244.94 | |
| J2360 | Injection, orphenadrine citrate, up to 60 mg | <1% | 63 | $238.84 |
| 95816 | <1% | 29 | $227.69 | |
| 84156 | <1% | 53 | $225.64 | |
| 72072 | <1% | 12 | $225.49 | |
| 80358 | <1% | 12 | $224.99 | |
| J3010 | Injection, fentanyl citrate, 0.1 mg | <1% | 1,814 | $220.28 |
| 80347 | <1% | 12 | $217.25 | |
| 73552 | <1% | 12 | $210.26 | |
| J7040 | Infusion, normal saline solution, sterile (500 ml = 1 unit) | <1% | 926 | $209.64 |
| 82140 | <1% | 50 | $201.03 | |
| 86431 | <1% | 24 | $199.12 | |
| 80353 | <1% | 12 | $192.77 | |
| 72114 | <1% | 12 | $189.74 | |
| J1200 | Injection, diphenhydramine hcl, up to 50 mg | <1% | 1,127 | $178.41 |
| J7999 | Compounded drug, not otherwise classified | <1% | 518 | $163.75 |
| 87430 | <1% | 13 | $149.76 | |
| 82950 | <1% | 29 | $148.94 | |
| 36600 | <1% | 13 | $141.10 | |
| 80051 | <1% | 28 | $137.97 | |
| 82009 | <1% | 30 | $119.55 | |
| J2704 | Injection, propofol, 10 mg | <1% | 1,499 | $98.86 |
| 87210 | <1% | 15 | $98.33 | |
| J1030 | Injection, methylprednisolone acetate, 40 mg | <1% | 44 | $97.67 |
| 80069 | <1% | 12 | $95.96 | |
| J2250 | Injection, midazolam hydrochloride, per 1 mg | <1% | 1,801 | $84.38 |
| 87081 | <1% | 35 | $77.92 | |
| J2765 | Injection, metoclopramide hcl, up to 10 mg | <1% | 332 | $73.64 |
| J2060 | Injection, lorazepam, 2 mg | <1% | 387 | $73.43 |
| 84425 | <1% | 12 | $61.95 | |
| S0028 | Injection, famotidine, 20 mg | <1% | 215 | $59.93 |
| J2001 | Injection, lidocaine hcl for intravenous infusion, 10 mg | <1% | 1,839 | $53.46 |
| S0119 | Ondansetron, oral, 4 mg (for circumstances falling under the medicare statute, use hcpcs q code) | <1% | 170 | $46.94 |
| S0020 | Injection, bupivicaine hydrochloride, 30 ml | <1% | 174 | $37.35 |
| 88304 | <1% | 37 | $28.15 | |
| J0690 | Injection, cefazolin sodium, 500 mg | <1% | 52 | $25.48 |
| J3480 | Injection, potassium chloride, per 2 meq | <1% | 71 | $25.05 |
| J7512 | Prednisone, immediate release or delayed release, oral, 1 mg | <1% | 454 | $17.67 |
| J7620 | Albuterol, up to 2.5 mg and ipratropium bromide, up to 0.5 mg, fda-approved final product, non-compounded, administered through dme | <1% | 602 | $13.40 |
| J1940 | Injection, furosemide, up to 20 mg | <1% | 19 | $3.30 |
| J7613 | Albuterol, inhalation solution, fda-approved final product, non-compounded, administered through dme, unit dose, 1 mg | <1% | 69 | $2.26 |
| Q0243 | Injection, casirivimab and imdevimab, 2400 mg | <1% | 41 | $0.22 |
| 97165 | 0% | 14 | $0.00 | |
| A9579 | Injection, gadolinium-based magnetic resonance contrast agent, not otherwise specified (nos), per ml | 0% | 67 | $0.00 |
| 96376 | 0% | 64 | $0.00 | |
| 94640 | Pressurized or nonpressurized inhalation treatment for acute airway obstruction | 0% | 20 | $0.00 |
| J8501 | Aprepitant, oral, 5 mg | 0% | 14 | $0.00 |
| Q9957 | Injection, perflutren lipid microspheres, per ml | 0% | 28 | $0.00 |
| J2919 | Injection, methylprednisolone sodium succinate, 5 mg | 0% | 51 | $0.00 |
| J0136 | Injection, acetaminophen (b braun), not therapeutically equivalent to j0131, 10 mg | 0% | 36 | $0.00 |
| J1171 | Injection, hydromorphone, 0.1 mg | 0% | 111 | $0.00 |
| J0295 | Injection, ampicillin sodium/sulbactam sodium, per 1.5 gm | 0% | 14 | $0.00 |
| 97161 | 0% | 14 | $0.00 | |
| 96136 | 0% | 24 | $0.00 | |
| J0665 | Injection, bupivicaine, not otherwise specified, 0.5 mg | 0% | 15 | $0.00 |
| J1650 | Injection, enoxaparin sodium, 10 mg | 0% | 14 | $0.00 |
| J2916 | Injection, sodium ferric gluconate complex in sucrose injection, 12.5 mg | 0% | 32 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialFRITZ, BRIAN (CFO)
| Provider | Location | Paid |
|---|---|---|
| Upmc Horizon | Greenville, PA | $8.63M |
| Upmc ST Margaret | Pittsburgh, PA | $5.40M |
| Upmc Jameson | New Castle, PA | $3K |
| Upmc Horizon | Greenville, PA | $1K |
| Upmc ST. Margaret | Pittsburgh, PA | $948.62 |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.